Skip to content
15% off your first order15% off your first order

MOTS-c 20 mg cartridge

Metabolic energy

Investigated for mitochondrial signaling and energy output.

$109 when in stock

Format. Vial or pen?

Pen cartridge sold out · the vial is in stock

Shop the vial · from $99
  • Ships from Canada in 1–2 business days
  • Free shipping over $120
  • Place your order, then send the e-Transfer. We pack it as soon as it arrives.

For research use only. Not for human consumption.

Compare. Side by side, from the research.

About MOTS-c

MOTS-c is a peptide encoded in mitochondrial DNA. Research examines its role as a signal between the mitochondria and the nucleus, particularly under metabolic stress.

How it works

Mitochondrial Origin
Encoded within mitochondrial DNA and studied as a signal between the mitochondria and the rest of the cell.
Metabolic Response
Explored in research on AMPK-associated pathways governing how cells manage energy availability and stress.
Read the full research

What you need

  • Reusable Metal Pen
  • Alcohol Wipes
  • A protocol guide comes with every order

Shipping & payment

  • Packed and dispatched within 1–2 business days
  • Delivered across Canada in 2–5 business days, tracked
  • Temperature-controlled packaging where the product needs it
  • Free shipping on orders over $120
  • Prices in CAD · pay by Interac e-Transfer
Format
Single cartridge for the reusable CoreX pen
Strength
20 mg per cartridge
Storage
Refrigerate, away from light. Once reconstituted, keep refrigerated and use within the window on the insert.
Route in research
Subcutaneous
SKU
MS20SC
Purity
High-performance liquid chromatography (HPLC), by an independent laboratory
Identity
Mass spectrometry, on the same batch
How often
Every batch
COA
The certificate of analysis is matched to the lot code printed on your vial
Evidence
Preclinical

Check your lot

Every vial carries a lot code. Enter it, or scan the QR on the label, to see its expiry and certificate of analysis.

PreclinicalPublished research on MOTS-c consists mainly of animal and cell studies along with review articles, and no late-stage clinical trials or regulatory approvals are described.

What research examines

  • Metabolic homeostasis, obesity and insulin resistance in animal models
  • Hyperglycemia and insulin resistance in gestational diabetes research
  • Pancreatic islet cell senescence and diabetes onset
  • Bone metabolism regulation
  • Lung ischemia-reperfusion injury and antioxidant gene activation
  • Ovarian cancer progression in laboratory studies

Reported in studies

  • Human safety data are limited
  • Adverse events are not summarized in the cited studies
  • Long-term effects in humans have not been characterized
Read the full research page· 5 cited studies

Published research protocols

5 mg, 3x/week, am fasted

Research protocols have used 500–5,000 mcg per administration, 3 times per week (morning, fasted), in 8-week blocks with 4 weeks off.

For research use only. These figures summarize published research protocols. They are not instructions or medical advice.

Measure with the calculator

CoreX AI

Ask about MOTS-c

Plain answers, from the basics to the studies.

Research information, not medical advice.

Often researched with MOTS-c

Researched for energy & metabolism.

Shop Energy & metabolism

FAQ

Questions, answered

  • MOTS-c is a peptide encoded within mitochondrial DNA rather than nuclear DNA. It is classed as a mitochondrial-derived peptide and is studied as a signaling molecule that carries information between the mitochondria and the rest of the cell. Research interest centers on its role under metabolic stress, where it has been examined for effects on how cells manage energy availability, and it is generally grouped with compounds studied in longevity and metabolic research.

  • Research describes MOTS-c as translocating to the nucleus when cells are under metabolic stress. Once there, it has been studied for effects on genes that govern metabolic homeostasis, largely through AMPK-associated pathways that help regulate cellular energy balance. One lung injury study reported nuclear translocation dependent on MYH9 and activation of antioxidant genes. These mechanisms come primarily from animal and cell research and have not been confirmed in human trials.

  • A frequently cited study reported that MOTS-c promoted metabolic homeostasis and reduced obesity and insulin resistance in experimental models. Other work has examined hyperglycemia and insulin resistance in gestational diabetes, pancreatic islet cell senescence and diabetes onset, bone metabolism, lung ischemia-reperfusion injury, sepsis-induced cardiomyopathy, and ovarian cancer progression. Several reviews also discuss its links to stress, metabolism and aging. This work is largely preclinical, and findings should not be taken as established human outcomes.

  • Human safety data for MOTS-c are limited. The available literature is dominated by animal studies, cell experiments and reviews, and adverse events are not summarized in the cited studies. Long-term effects, interactions and contraindications in humans have not been characterized. Because of these gaps, the safety profile of MOTS-c remains uncertain, and conclusions drawn from preclinical models may not reflect effects in people.

  • Research protocols have used 500 to 5,000 mcg per administration by the subcutaneous route, three times per week in the morning under fasted conditions. These protocols have been run in 8-week blocks followed by 4 weeks off. This information describes published research practice only and is not a recommendation. Each CoreX order ships with a protocol guide for laboratory reference.

Vial

Senescent-cell research

FOXO4 10 mg

$219/ 10 mg

Vial · Pen

Skin renewal

GHK-Cu · 3 sizes

$39/ 50 mg